Lilly Says It Will Raise Drug Prices in Europe, Responding to Trump Threats
Eli Lilly raised prices of diabetes and weight-loss drugs in Canada and the UK due to U.S. policy, with some prices increasing by up to 170%, analysts said.
Summary by biopharmadive.com
7 Articles
7 Articles
07:29 The American pharmaceutical group is responding to President Donald Trump's demand to raise drug prices abroad in order to lower them in the US.
·Belgium
Read Full ArticleEli Lilly says it will raise drug prices in Europe to ‘make them lower’ in U.S
Eli Lilly said Thursday that it would increase the prices of medicines in Europe and other developed markets “in order to make them lower” in the U.S., an apparent response to the Trump administration’s calls to do so. It singled out the list price of its popular weight-loss drug in the U.K. as…
Lilly plans to raise prices in Europe in response to Trump's 'most favored nation' push
Eli Lilly on Thursday took a page from President Donald Trump's playbook and will ask Europe to pay more for pharmaceuticals over the next several weeks. Calling the change a "rebalancing," the Indianapolis drugmaker ...
Coverage Details
Total News Sources7
Leaning Left0Leaning Right0Center3Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium